ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES

Marija Dimitrovska

doi:10.35120/medisij040403d

Authors

Marija Dimitrovska Zentiva Pharma Makedonija, R.N. Macedonia Author

DOI:

https://doi.org/10.35120/medisij040403d

Keywords:

Artificial intelligence, drug discovery, machine learning, clinical trials, pharmaceutical innovation

Abstract

Drug development is a complex, time-consuming, and costly process, with average timelines exceeding a decade and success rates remaining low. Artificial intelligence (AI) has emerged as a transformative tool with the potential to accelerate and optimize every stage of the drug development pipeline. By leveraging vast biomedical datasets, advanced algorithms, and computational power, AI can support target identification, predict molecular properties, design novel compounds, and optimize clinical trial processes. Recent advances in machine learning, deep learning, and natural language processing have demonstrated the ability to uncover patterns and relationships beyond the reach of conventional approaches. AI-driven platforms have already contributed to the discovery of promising therapeutic candidates and facilitated more efficient decision-making. Despite significant progress, challenges remain in data quality, model interpretability, regulatory acceptance, and ethical considerations. This review provides a comprehensive overview of AI methodologies applied to drug discovery and development, highlights notable case studies from academia and industry, and critically examines both the opportunities and limitations of these technologies. We also explore future directions, including integration with complementary technologies, collaborative data sharing models, and evolving regulatory frameworks. By evaluating the current state and potential of AI in pharmaceutical research, this article aims to provide scientists, clinicians, and policymakers with a clear understanding of how AI can be harnessed to transform the drug development landscape.

Downloads

Download data is not yet available.

References

Arabi, A. A. (2020). Artificial intelligence in drug design: algorithms, applications, challenges and ethics. Future Drug Discovery. DOI: https://doi.org/10.4155/fdd-2020-0028

Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2021). Artificial intelligence in drug discovery — recent advances and future perspectives.

Clevert, D.-A. (2025). Advanced machine learning for innovative drug discovery. Journal of Cheminformatics, 17(122) DOI: https://doi.org/10.1186/s13321-025-01061-w

Dhudum, R., Ganeshpurkar, A., & Pawar, A. (2024). Revolutionizing drug discovery: A comprehensive review of AI applications. Drugs Drug Candidates, 3(1), 148–171. DOI: https://doi.org/10.3390/ddc3010009

Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A. (2020). Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades. Drug Discovery Today, 25(9), 1702–1709 DOI: https://doi.org/10.1016/j.drudis.2020.07.001

Hasselgren, C., & Oprea, T. I. (2024). Artificial Intelligence for Drug Discovery: Are We There Yet? Annual Review of Pharmacology and Toxicology, 64, 527–550. DOI: https://doi.org/10.1146/annurev-pharmtox-040323-040828

Kazi, A. J., Gurav, M. A., Patil, S. R., Ritthe, P. V., Rudrurkar, M. N., Dharashive, V. M., & Shafi, D. S. (2024). The impact of artificial intelligence on drug discovery; a comprehensive review. Asian Journal of Pharmaceutical Research and Development, 12(2), 171–178.

Kim, H., Kim, E., Lee, I., Bae, B., Park, M., Nam, H., et al. (2021). Artificial intelligence in drug discovery: A comprehensive review of data-driven and machine learning approaches. Biotechnol. Bioprocess Eng., 25(6), 895–930 DOI: https://doi.org/10.1007/s12257-020-0049-y

Li, K., Xiong, Y., Zhang, H., Cai, X., Du, B., Hu, W., et al. (2025). Small molecule drug discovery through deep learning: progress, challenges, and opportunities DOI: https://doi.org/10.1109/ICWS67624.2025.00135

Qin, S., Deng, B., Mo, D., Zhang, Z., Wei, X., & Ling, Z. (2025). Harnessing machine learning and AI-driven analytics to identify novel drug targets and predict chemotherapy efficacy in NSCLC. Frontiers in Pharmacology, 16, Article 1555040. DOI: https://doi.org/10.3389/fphar.2025.1555040

Vefghi, A., Rahmati, Z., & Akbari, M. (2025). Drug-target interaction/affinity prediction: Deep learning models and advances review. DOI: https://doi.org/10.1016/j.compbiomed.2025.110438

Zhang, O. et al. (2025). Graph neural networks in modern AI-aided drug discovery. arXiv. https://doi.org/ DOI: https://doi.org/10.1021/acs.chemrev.5c00461